| Christopher Allan Buck, DDS | |
|
1713 N Main Street, West Bend, WI 53090 | |
| (262) 334-4083 | |
| (262) 334-4996 |
| Full Name | Christopher Allan Buck |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 1713 N Main Street, West Bend, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184760894 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 3023 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Allan Buck, DDS 1713 N Main Street, West Bend, WI 53090 Ph: (262) 334-4083 | Christopher Allan Buck, DDS 1713 N Main Street, West Bend, WI 53090 Ph: (262) 334-4083 |
News Archive
A team of researchers at the Institute of Infectious Diseases (IFIK) at the University of Bern and the Institute of Virology and Immunology (IVI) has utilized a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals. This way, the team can determine which animals are susceptible to SARS-CoV-2 infection.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.
Studies Suggest that ErbB4 Receptor Activation May Be a Novel Therapeutic Avenue for Intestinal Diseases Involving Epithelial Cell Death, According to Research Published in The American Journal of Pathology
› Verified 3 days ago
Michael Scott Kopecky, DDS MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 145 N 18th Avenue, West Bend, WI 53095 Phone: 262-334-3084 Fax: 262-334-3552 | |
Dr. Kristine Kim Neuburg, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 533 South Main St., The Gentle Dental Emporium Llc, West Bend, WI 53095 Phone: 262-338-8704 Fax: 262-338-9140 | |
Dr. Kent Alan Zocher, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1500 South Main St, West Bend, WI 53095 Phone: 262-338-0022 Fax: 262-338-7982 | |
Dr. Christopher Flood, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1625 W Paradise Dr, West Bend, WI 53095 Phone: 262-338-2992 | |
Dr. Tyler Meadows Davis, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1201 Oak St Ste D, West Bend, WI 53095 Phone: 262-310-1860 Fax: 262-310-1861 | |
Daniel H Roth, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1713 Vogt Dr, West Bend, WI 53095 Phone: 262-334-3070 |